CervoMed Inc.
CRVOUS売上高
$4M
百万USD
営業利益
$-28M
百万USD
純利益
$-27M
百万USD
ROE
-148.0%
最新FY
EPS
-
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | - | $-5M | $83420184.00 |
| FY2021 | Q2 | - | $-4M | $101903979.00 |
| FY2021 | Q3 | - | $-12M | $101903979.00 |
| FY2021 | FY | - | $-24M | $97626748.00 |
| FY2022 | Q1 | - | $-5M | - |
| FY2022 | Q2 | - | $-4M | - |
| FY2022 | Q3 | - | $-3M | - |
| FY2022 | FY | - | $-16M | $2038891.00 |
| FY2023 | Q1 | - | $-4M | - |
| FY2023 | Q2 | - | $-2M | - |
| FY2023 | Q3 | $2M | $2M | $-0.70 |
| FY2023 | FY | $7M | $-2M | - |
| FY2024 | Q1 | $2M | $-3M | - |
| FY2024 | Q2 | $3M | $-2M | - |
| FY2024 | Q3 | $2M | $-5M | $-0.55 |
| FY2024 | FY | $10M | $-16M | - |
| FY2025 | Q1 | $2M | $-5M | - |
| FY2025 | Q2 | $2M | $-6M | - |
| FY2025 | Q3 | $0M | $-8M | - |
| FY2025 | FY | $4M | $-27M | - |
| FY2026 | Q1 | $0M | $-8M | - |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | - | - | - | $7M | $10M | $4M |
| 営業利益 | $-18M | $-11M | $-19M | $-12M | $-16M | $-25M | $-16M | $-8M | $-18M | $-28M |
| 純利益 | $-18M | $-1M | $-18M | $-12M | $-14M | $-24M | $-16M | $-2M | $-16M | $-27M |
| 総資産 | $17M | $26M | $18M | $24M | $28M | $38M | $23M | $10M | $43M | $23M |
| 純資産 | $9M | $21M | $16M | $20M | $25M | $35M | $20M | $7M | - | - |
| 自己資本 | $9M | $21M | $16M | $20M | $25M | $35M | $20M | $7M | $39M | $18M |
| 営業CF | $-11M | $-12M | $-11M | $-10M | $-14M | $-15M | $-15M | $-7M | $-17M | $-23M |
| EPS | - | $-1.94 | $-8.21 | $6706509.00 | $53831973.00 | $97626748.00 | $2038891.00 | - | - | - |
| BPS | $0.89 | $0.42 | $4.62 | $0.58 | $0.24 | $0.34 | $9.91 | $1.20 | $4.50 | $1.97 |
| ROE | -196.4% | -6.4% | -117.7% | -58.6% | -57.2% | -69.0% | -77.1% | -29.4% | -41.6% | -148.0% |